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ABSTRACT 
 
Purpose: The confirm that structures presumed to be goblet cells observed using laser 
scanning confocal microscopy (LSCM) are actually goblet cells.  
Methods: Cell morphology was evaluated using LSCM and immunohistochemistry was 
performed on a single sample of pterygium freshly excised a 44 year old male. After viewing 
what were believed to be goblet cells in the excised tissue using LSCM, laboratory 
microscopy and immunohistochemistry were undertaken on the tissue sample. Goblet cells 
were identified by a combination of classic morphologic appearance and the use of 
immunofluorescence to antibodies for mucin 5AC and cytokeratin-7 (CK-7). The LSCM and 
immunohistochemistry results were compared. 
Results: Using LSCM, Goblet cells were observed in conjunctival tissue between 7 and 41 
µm deep, at the level of the superficial basal cells of the excised pterygium tissue. Goblet 
cells were estimated to have a diameter 35 to 40 µm near the surface and 20 to 30 µm in the 
deeper layers. A small dark dot was visible in some goblet cells, potentially indicating the 
nuclei, or perhaps the opened apical portion of the cell, representing the site of mucin release. 
Goblet cells were more reflective and larger than the surrounding cells. Positively stained 
goblet cells in immunofluorescence showed a similar distribution pattern to those observed 
during LSCM examination. The tissue sample also stained intensely for the goblet cell-
specific mucin type 5AC. 
Conclusions: The pattern of discrete, large reflective cells observed using LSCM are likely 
to be goblet cells. 
 
  
The structures presumed to be conjunctival goblet cells observed using laser scanning 
confocal microscopy (LSCM)1 have not, to date, been verified as such. If LSCM is to be 
adopted as non-invasive alternative to the mildly invasive technique of impression cytology 
for assessing goblet cell density, as has been suggested recently, then the presumption that the 
entities being observed using LSCM are actually goblet cells needs to be tested.  
 
Under microscopic examination, specific cell types in human tissue biopsy samples can be 
distinguished from surrounding cells by morphological appearance. Each cell types has 
unique antibodies that facilitate characterization of cell phenotype, which can be analysed 
using methods such as immunofluorescence staining. Conjunctival goblet cells are found 
scattered among the epithelial lining of the conjunctival epithelium, having a height of three 
to four times that of their width and a distinct balloon-like appearance.2  
 
Goblet cells be further characterised in vitro using immunohistochemistry analysis, which 
allows visual verification of antigen-antibody binding using either a coloured histochemical 
reaction or fluorescence.3 Conjunctival goblet cells express a positive MUC5AC response to 
antibodies. Squamous cells stain negatively for cytokeratin 7 (CK-7), unlike the cytoplasm of 
goblet cells, which is identified using CK-7.2 
 
In healthy individuals, LSCM reveals goblet cells to be approximately 25 to 30 µm in 
diameter,4,5 hyper-reflective,6,7 larger than surrounding cells,8 and round7 to oval-shaped,9 
often with visible nuclei.10 Pterygium, which is a breakdown in the normal peripheral or 
limbal structure and emigration of conjunctival tissue onto the cornea, has been assessed 
using conjunctival impression cytology (CIC)11 and there is no evidence of morphological 
changes to the goblet cells in this condition.  
 
This study aims to verify that the entities believed to be goblet cells as imaged with LSCM 
are indeed goblet cells as confirmed by immunohistochemistry. Our approach will be to 
assess a fresh conjunctival biopsy sample – first using LSCM and subsequently staining the 
sample to confirm the cell type, in this instance using antibodies for mucin-type 5AC.  
 
METHODS 
This observational study was conducted following approval from the QUT Research Ethics 
Committee and the Queensland Eye Institute (QEI) Human Research Ethics Committee.  
 To avoid the use of fixatives, which can induce artefacts changes in excised tissue samples, 
we conducted the experiment a fresh biopsy. Since autolytic changes can occur in tissue 
preserved at 37 °C, and be destructive to cell morphology, a sample of pterygium was 
prepared for observation approximately 30 minutes following surgical removal from a 44 
year old male, with the consent of the patient. A biopsy section of approximately 800 µm² 
was obtained from the lower edge of the triangular- or wing-shaped portion of the pterygium.  
 
The tissue biopsy section was divided into two portions and immersed in Dulbecco's 
Modified Eagle's Medium (DMEM) (11320, Gibco Invitrogen, USA) with 5mM L-
glutamine, 100 µg/ml streptomycin and 10% heat-inactivated foetal calf serum (HI-FCS) 
(10101-145, Gibco Invitrogen, USA). Both samples were placed in a well plate sample holder 
(PSHT004R1, Millicell, Merk Australia), transferred to the laboratory and held at 4°C for 30 
min during the blocking step, which was required to prevent non-specific antibody binding. 
 
Laser scanning confocal microscopy 
A Heidelberg Retinal Tomographer III, with Rostock Corneal Module  attachment 
(Heidelberg Engineering, Germany), was used to observe the tissue section. The biopsy 
section was placed on the centre of the Tomocap. Excess liquid from the medium was not 
removed as this provided better observation and image resolution. The sample was carefully 
handled using fine surgical tweezers with low pressure to avoid tissue damage. Goblet cells 
were identified and images were captured in steps of 1 to 2 µm deep using the section mode 
of the confocal microscope, without moving the tissue. 
 
Immunohistochemistry 
After LSCM observation, immunofluorescence was performed on the same section of tissue 
using a double-staining method. One half of the biopsy was incubated for 2 h at 37°C in 
primary antibodies anti-cytokeratin 7 (mouse anti-human CK-7; concentration: 1mg/ml, 
Abcam, AU), which detects mucus-secreting cell membranes, diluted 1:500 in phosphate-
buffered saline (PBS). Antibody anti-mucin 5AC (rabbit anti-human MUC5AC; 
concentration: 1mg/ml, Abcam, AU) was diluted 1:500 in PBS. After washing three times 
(for 2 min each time) in PBS using an orbital shaker, the secondary antibodies, donkey anti-
mouse fluorescein isothiocyanate (FITC) (concentration: 2mg/ml, Abcam, AU) and donkey 
anti-rabbit immunoglobulin G (IgG) tetramethylrhodamine (TRITC) (concentration: 2mg/ml, 
Abcam, AU) were diluted 1:300 in PBS and the tissue was incubated for 2 h at 37 °C. After 
washing three times (for 2 min each time) in PBS using an orbital shaker, 1µg/ml of 4’, 6-
diamidino-2-phenylindole, dihydrochloride (DAPI), diluted 100 times in PBS for 10 min, was 
used to identify cell nuclei. The second half of the biopsy was immersed in 10% HI-FCS and 
used as a negative control (primary antibody step omitted). 
 
Laboratory confocal imaging 
Prior to imaging, the tissue was placed onto a glass coverslip containing one drop of PBS. 
Multiple label immunofluorescence confocal z-stack images were collected and analysed 
using a Nikon A1R confocal microscope with 10x and 20x water immersion objective lenses 
(Nikon Instruments Inc., Melville, NY). DAPI, FITC and TRITC were excited with 405 nm, 
488 nm, and 561 nm lasers, respectively. 
 
RESULTS 
Laser scanning confocal microscopy 
Using LSCM, goblet cells were observed in conjunctival tissue between 7 and 41 µm deep, at 
the level of the superficial basal cells of the pterygium section. Some goblet cells were 
observed to be brighter than others, possibly due to overlapping cells. This suggested that 
goblet cells were located at different depths in the tissue. Goblet cells were estimated to be 
approximately 20 to 30 µm in diameter, although goblet cell diameter varied according to 
depth in the tissue and cell cycle. Goblet cells appeared to have a larger diameter in the 
superficial layers (35 to 40 µm). Round goblet cells were smaller in diameter than oval-
shaped goblet cells. A small dark dot was visible in some goblet cells, potentially indicating 
the nucleus, or perhaps the opened apical portion, indicating the site of mucin release. Goblet 
cells were also more reflective and larger than the surrounding cells. A diagonal hyper-
reflective line can be across the sample in Figure 1A; this may be a processing artefact or a 
fold of the tissue sample. Goblet cells appeared to be more distinct and more dense in the 
lower part of the field. 
 
Immunohistochemistry 
Positively stained goblet cells in immunofluorescence showed a similar distribution pattern to 
those observed during LSCM examination (Figure 1). A 20x objective lens was used to 
analyse cell morphology. The 200 µm² white box depicted in Figure 1B was magnified to 
form Figure 1C. Three different goblet cell appearances can be discerned. Larger oval-shaped 
cells appear to express more MUC5AC and lack nuclei and absent nuclei, whereas the 
smaller round cells express less MUC5AC and display distinct apical nuclei. Other goblet 
cells have distinct balloon-like appearance and fail to express MUC5AC; however, the edges 
of the nuclei were visible, indicating that they were positive for CK-7. 
 
Goblet cells exhibited intense staining for CK-7 (Figure 2A). The tissue sample also stained 
intensely for the goblet cell-specific mucin type, MUC5AC (Figure 2B), whereas 
deoxyribonucleic acid (DNA) expression was indicated by strong binding to DAPI in the 
nuclei of all cells (Figure 2C). Immunofluorescent staining with the isotype control using 
secondary antibodies showed no apparent immunoreactivity (Figure 2D). Thus recognition of 
non-goblet cells was also possible by overlapping the images, as shown in Figure 1B. 
 
Secondary antibody binding was examined in the negative control and resulted in a negative 
signal, indicating that there was not contamination and non-endogenous labelling (Figure 
1D). 
 
DISCUSSION 
We have succeeded in imaging and identifying, for the first time, goblet cells in conjunctiva 
using LSCM and immunohistochemistry in a human pterygium biopsy sample; however, we 
failed to observe an identical portion of tissue as a result of the repositioning and 
manipulation of the tissue during transfer between the two observation platforms, and 
modification of the tissue during the staining procedure. Nevertheless, it is reasonable to 
assume that the structures observed in the tissues by LSCM were in fact goblet cells, based 
upon all structures observed using both techniques. 
 
Morphological analysis with LSCM allowed the identification of goblet cells and surrounding 
epithelial cells. In some parts of the tissue, epithelial cells were observed to have a distinct 
cell membrane with bright or dark spots. The cytoplasm was observed in some cells with low 
contrast. Nuclei were difficult to identify in most cells, possibly due to the poor resolution of 
the small nuclei (approximately 3 to 5 µm).  When they were observed, nuclei appeared dark 
and round in shape. Goblet cells appeared bright, were sometimes round to oval-shaped, and 
demonstrated rich contrast. They were considerably larger than non-goblet cells, with defined 
borders and varied sizes, between 20 and 30 µm in diameter. These observations have been 
observed previously in healthy individuals by other authors using the same technique.7, 11, 12 
 LSCM has the advantage of allowing in vivo assessment of goblet cells at different depths in 
the epithelium, and offers the capability of assessing cells before and after interventions, 
without the need for tissue removal and sample processing. A key limitation of this technique 
is the relatively small field of view (400 x 400 µm) and fixed magnification, compared with 
fluorescence and confocal microscopes which provide variable magnification. 
 
Whereas various morphological forms of goblet cells can be analysed using LSCM,8,12,13 
immunohistochemistry adds an additional dimension to cell characterisation. Three distinct 
morphological forms of goblet cells were identified in our pterygium sample, based on 
positive staining for MUC5AC and/or CK-7, as well as morphologically distinct balloon-like 
appearances of some cells. Also, MUC5AC expression was shown to be more intense in oval-
shaped cells than in round cells, which we attribute to a higher number of mucin granules 
within goblet cells. In the magnified portion of the tissue sample shown in Figure 2C, some 
cell nuclei were positively outlined with CK-7 but lacked MUC5AC expression and balloon-
like morphology. This may be due to incomplete ion of some goblet cells.  Such cells have 
been observed in rabbit and human cell culture studies.14 Another possible explanation for 
this staining pattern is that these cells represent either degenerating limbal epithelial cells in 
the pterygium, or morphologically altered cells resulting from tissue damage due to the 
surgical excision or laboratory processing. 
 
Cross-validation in this work of LSCM and immunohistochemistry observation and 
characterisation of goblet cells in a single pterygium tissue sample strongly supports the 
notion that presumed goblet cells observed using LSCM are indeed this cell type.  
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Figure legends 
 
Figure 1 Characterization of goblet cells from pterygium biopsy using laser scanning 
confocal microscopy and immunohistochemistry. (A) In vivo LSCM image 
shows distinct balloon-like cell appearance (thick arrow) compared to the 
squamous non goblet cells (thin arrow). (B) Immunofluorescence image of same 
biopsy sample triple-labelled using FITC+TRITC+DAPI. The thin arrow 
represents positive stain for goblet cells and the thick arrow represents negative 
stain and the presence of cell nuclei assumed to be squamous non-goblet cells. 
(C) 2X magnification of white box in B showing three distinct cell types with 
positive staining for CK-7. The dashed arrow indicates a large, oval-shaped 
goblet cell with positive MUC5AC expression (red). The thick arrow indicates a 
smaller, round-shaped goblet cell with minimal red staining. The thin arrow 
indicates a possibly immature goblet cell lacking either a balloon-like 
appearance or MUC5AC expression. 
 
Figure 2  Immunolocalization of goblet cell markers in the pterygium biopsy. (A) Goblet 
cell cytoplasm display intense staining for CK-7 (green). (B) Location of mucin 
type MUC5AC (red). (C) DNA expression indicated by strong binding to DAPI 
in the nuclei of all cells (blue). (D) anti-mouse and anti-rabbit isotypes control. 
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